Lantern Pharma Inc. (Nasdaq: LTRN)
Develops precision cancer drugs and revitalizes abandoned drugs using machine learning and genomic data, focusing on personalized therapy through AI and patient stratification.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
